Background Alpha-fetoprotein has been used as a predictor of recurrence for hepatocellular
carcinoma and disease-free survival post-resection. Studies in East Asia have shown that …

Background and aim: To evaluate early serial AFP changes in responders and non-
responders to locoregional therapy and identify differences between significant AFP …

Alpha-fetoprotein (AFP) represents the most important biomarker for hepatocellular
carcinoma (HCC). The aim of this study was to identify the optimal staging system to predict …

Background: Although many studies have confirmed the prognostic value of preoperative
alpha-fetoprotein (AFP) in patients with hepatocellular carcinoma (HCC), no one study has …

Background. This study was conducted to investigate the effect of alpha‐fetoprotein (AFP)
ratio on the prognosis of AFP‐positive hepatocellular carcinoma (HCC) patients after …

Objective To explore the correlation between alpha fetoprotein (AFP) and the prognosis of
hepatocellular carcinoma after hepatectomy in an ethnic Chinese population. Methods This …

Background We evaluated treatment modalities and survival in patients with hepatocellular
carcinoma (HCC), by pre-treatment and 3-month post-treatment serum alpha-fetoprotein …

Hypothesis An elevated serum α-fetoprotein (AFP) level before orthotopic liver transplant
(OLT) is predictive of mortality after OLT for hepatocellular carcinoma (HCC). Design …

Alpha‐fetoprotein (AFP), des‐γ‐carboxy prothrombin (DCP), and lens culinaris agglutinin‐
reactive fraction of AFP (AFP‐L3) have been developed with the intent to detect …

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) can result from hepatitis C virus
(HCV)-related liver disease and is the fastest-growing cause of cancer-related death in the …